News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Merck & Co., Inc. Announces Second Quarter 2011 Financial Results
July 29, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2011.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Merck & Co.
MORE ON THIS TOPIC
Earnings
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout
April 30, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Mucinex maker hits New Jersey with more layoffs
April 30, 2026
·
47 min read
·
BioSpace Editorial Staff
IPO tracker
Avalyn beats expectations with $300M debut
April 30, 2026
·
11 min read
·
Editorial Team
Earnings
Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth
April 30, 2026
·
2 min read
·
Annalee Armstrong